List of Therapeutic Companies in Kentucky - 8
Search through the full list with powerful filtering options
Want this in Excel? Get Quote NowCompany | About |
---|---|
Bexion Pharmaceuticals Covington, Kentucky, United States | Bexion Pharmaceuticals is a mid-stage clinical company developing life-changing treatments in Oncology and CNS. The company’s lead compound, BXQ-350, is a novel S1P modulator. With our highly experienced biotech leadership team and expertise in Oncology, we are urgently progressing our pipeline to develop life-changing oncology therapies on our path to becoming a leading biotech/pharmaceutical company. |
Gismo Therapeutics Lexington, Kentucky, United States | GISMO THERAPEUTICS INC. is a privately funded biotech start-up company incorporated in 2011. The company is developing novel oral therapeutics for Alzheimer’s and Parkinson's Disease, based on a novel hypothesis and a novel mechanism of action. Gismo Therapeutics Inc. has ongoing research collaborations with US academic institutions. |
Hema Biologics Louisville, Kentucky, United States | HEMA Biologics is a privately held biopharmaceutical company exclusively focused on meeting the needs of patients living with the rarest bleeding disorders. We aspire to support patients living with these disorders, partner with the broader community that cares for them, and bring meaningful treatments and services to help better their daily lives. Our product development focus is on rare bleeding disorders. Our product development focus is for the treatment of hemophilia A or B with inhibitors. For people living with these disorders, every day brings challenges. Our primary goal is to advance the treatment and management of these conditions in the US to positively affect patients’ lives. HEMA Biologics takes pride in the heritage of LFB, the manufacturer of its products. LFB is a global leader in manufacturing safe, ultrapure plasma-based products as well as a pioneer in innovative recombinant technologies. We are excited to bring these products and technologies to North America. |
KBio 3700 airpark dr, owensboro, kentucky, united states | KBio aims to create a new generation of biologics using its plant-based platform that has demonstrated the ability to create drug candidates at a fraction of the time and cost of conventional platforms. The Company is focused on developing novel product candidates in two core areas: 1) Antibody therapies for areas of high unmet need; and 2) Pandemic preparedness and response using its plant-based production system to create antibodies and vaccines in shorter timeframes than industry norms. Formed in December 2021, KBio is a subsidiary of BAT with operations in the UK and U.S. |
Liberate Medical Crestwood, Kentucky, United States | Liberate Medical is a medical device company that develops neuromuscular electrical stimulation technology to improve the quality and reduce the cost of care for patients with pulmonary disorders. Liberate's lead product, the VentFree™ respiratory muscle stimulator. Invasive mechanical ventilation commonly weakens the breathing muscles, increasing the need for further ventilator support. VentFree applies proprietary, non-invasive, electrical stimulation to the expiratory muscles in synchrony with exhalation while a patient is on mechanical ventilation. This breakthrough therapy, which is quick and simple to use, is intended to reduce abdominal muscle atrophy and the time taken to liberate patients from mechanical ventilation. Reduced days on mechanical ventilation can potentially lead to reduced morbidity and mortality, improved quality of life, and considerable savings for the health care provider. |
NX PharmaGen Inc. 4350 Brownsboro Road, Louisville, Kentucky, USA, 40207 | NX PharmaGen develops blood-based molecular diagnostic testing products. |
Orthopeutics Lexington, Kentucky, United States | Nonsurgical solutions for back problems |
US WorldMeds Louisville, Kentucky, United States | US WorldMeds is a specialty pharmaceutical company that develops, licenses, and brings to market unique healthcare products designed to improve the lives of patients with challenging conditions and unmet medical needs. Organized on March 23, 2001 by current CEO Paul Breckinridge "Breck" Jones, US WorldMeds holds true to Breck’s vision of creating a sustainable, privately held specialty pharmaceutical company known for agility and personal attention to its products and stakeholders. Our dedication to improving patients’ lives can be seen both in the products that we market and the therapies that are currently under development. Each day, we work diligently to bring new therapies and new indications to patients across multiple therapeutic areas. In addition to our dedication to serving patients, we embrace a culture that values honesty, creativity, and action, integrity in relationships, a passion for success, and good stewardship of Company resources. We offer our employees exciting challenges, unique opportunities, and a fast-paced environment that emphasizes innovation and achievement. Our headquarters are in Louisville, Kentucky, but you can find our team and partners throughout the U.S. and across the globe. To learn more about our mission and values, and for all US WorldMeds information, visit our site: http://www.usworldmeds.com. You can also follow us on Twitter at @USWorldMeds. |